NEW YORK (GenomeWeb) – Mesa Biotech announced today that it has received CE marking for its molecular diagnostic assay to detect respiratory syncytial virus (RSV). The point-of-care test will now be will marketed by select distributors in the EU.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.